Supporting pharma companies to develop impactful strategies for market leadership with the customer at the center, has been our passion at Trilations for more than 20 years.
With the 4th annual “Pharma Customer Centricity Index” (PCCI) survey, we want to provide pharma companies with an objective view on their ‘Customer Centricity’ performance and what is driving this.
Therefore, we collected insights on both physician & patient centricity, but also on customer relationship & (omnichannel) interaction, scientific leadership, and much more.
Countries: EU5, USA, Brazil, Japan, China, Australia
Treatment areas: Oncology, Haematology, Dermatology, Rheumatology, Cardiology, Neurology
Respondents: 1.729 spezialized physicians
You can consult your Pharma Customer Centricity Index scores and those of competing pharma companies in our report below.
If you are interested in more detailed results, want to find out what is driving this and how to improve, please reach out to us.
I’d like to receive the Pharma Customer Centricity Index 2023 report
Feel free to browse through the content of past waves.
Discover the scope and results of the previous wave of our PCCI through this introductory video.
To truly understand what customer centricity means for the most important stakeholders, the patients, we sat down and listened to them in a US focus group.
Four patient advocates and three leading specialists shared their view with us regarding patient centricity and what this means in their daily lives. What is their definition of being customer-centric within pharma, what are the best practices and unmet needs, etc.Go to recordings
Great strategies are based on the right decisions. Trilations works closely with your internal leadership teams and provides you with business insights to ensure you take the right decisions.